Original Research

Remdesivir is Effective for Moderately Severe Patients: A Re-Analysis of the First Double-Blind, Placebo-Controlled, Randomized Trial on Remdesivir for Treatment of Severe COVID-19 Patients Conducted in Wuhan City

Shih WJ, Shen X, Zhang P, Xie T

Open Access Journal of Clinical Trials 2020, 12:15-21

Published Date: 30 July 2020